Zoono Group Limited

ZNO

AU000000ZNO4

Personal Products

Market Closed - Australian S.E. Other stock markets 01:24:21 2024-04-26 am EDT			5-day change	1st Jan Change
0.055 ^AUD	-9.84%		-8.33%	+25.00%

Apr. 23	Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18%	MT
Mar. 26	Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue	MT

Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022

August 24, 2022 at 07:39 pm EDT

Zoono Group Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was NZD 9.02 million compared to NZD 27.13 million a year ago. Net loss was NZD 11.39 million compared to net income of NZD 4.73 million a year ago.

Basic loss per share from continuing operations was NZD 0.0682 compared to basic earnings per share from continuing operations of NZD 0.0289 a year ago. Diluted loss per share from continuing operations was NZD 0.0682 compared to diluted earnings per share from continuing operations of NZD 0.0287 a year ago.

Latest news about Zoono Group Limited

Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18%	Apr. 22	MT
Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue	Mar. 25	MT
Zoono Group Says Unaware of Any Information for Share Price Fluctuation	Mar. 19	MT
Zoono Group Signs Exclusive Deal for Sale Promotion for Products; Shares Up 8%	Mar. 05	MT
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 21	CI
Zoono Group Delays Start of Up to AU$2.7 Million Rights Issue	Jan. 30	MT
Zoono Group Faces Charges from the New Zealand Commerce Commission	Dec. 20	MT
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
Zoono Group Limited Announces Change of Registered Address	22-11-01	CI
Zoono Group Limited Enters into Co-Development and Licence Agreement with Douglas Pharmaceuticals	22-10-16	CI
Zoono Group Limited Develops New Nasal Spray Product	22-10-16	CI
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-24	CI
Zoono Group Appoints CEO	22-04-01	MT
Zoono Group Limited Appoints Barry Woolcott as Group Chief Executive Officer	22-03-31	CI
Zoono Group Limited Enters into Two New Exclusive Distribution Agreements with Star Pharma Distributora de Medicamentos e Correlatos LTDA	22-03-31	CI
Zoono Group Limited(ASX:ZNO) dropped from S&P/ASX All Ordinaries Index	22-03-21	CI
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-23	CI
Zoono Signs Chinese Distribution Deal for Antimicrobial Product	22-02-01	MT
Zoono Group Limited Signs Distribution Agreement with China Animal Husbandry Group	22-01-30	CI
Apiam Animal Health's Distributor Gets US Regulatory Nod to Market Antimicrobial Technology	21-11-16	MT
Zoono Group Limited(ASX:ZNO) dropped from S&P/ASX Emerging Companies Index	21-09-20	CI
Zoono Group Limited(ASX:ZNO) dropped from S&P Global BMI Index	21-09-20	CI
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-25	CI
Zoono Group Elects Not to Pay A Dividend with Respect to the 2021 Year	21-08-25	CI

Chart Zoono Group Limited

Duration

Period

More charts

Company Profile

Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.

Sector

Personal Products

Calendar

2024-08-21 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Personal Products

	1st Jan change	Capi.
ZOONO GROUP LIMITED	+25.00%	7.66M
PROCTER & GAMBLE COMPANY	+10.07%	381B
COLGATE-PALMOLIVE COMPANY	+14.18%	74.67B
HINDUSTAN UNILEVER LIMITED	-16.59%	62.59B
ESTEE LAUDER	+0.82%	52.86B
KENVUE INC.	-12.40%	36.11B
BEIERSDORF	+3.54%	33.57B
ESSITY AB	+7.92%	17.29B
GODREJ CONSUMER PRODUCTS LIMITED	+6.30%	14.75B
DABUR INDIA LIMITED	-8.65%	10.82B